SANUWAVE Will Host a Conference Call on May 10, 2024 at 8:30 AM (ET) to Present Q1 Financial Results

About this update from Sanuwave Health, Inc.

EDEN PRAIRIE, MN - (NewMediaWire) - May 07, 2024 - SANUWAVE Health, Inc. (the "Company" or " Sanuwave ) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, May 10, 2024 , at 8:30 AM (ET) to present the Q1 2024 financial results. Telephone access to the call will be available by dialing the following numbers: Participant Dial -in Information Toll Free: 1-800-245-3047 Toll/International: 1-203-518-9765 OR click the link for instant telephone access to the event. https://viavid.webcasts.com/starthere.jsp?ei=1665712&tp_key=5ceebf04ab Materials for the conference call will be included on the Companys website at www.sanuwave.com/investors . A replay will be made available through June 3, 2024 : Toll-Free: 1-844-512-2921 or 1-412-317-6671 Replay Access ID: 1155590 About SANUWAVE SANUWAVE Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. SANUWAVE's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the bodys normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions. Forward-Looking Statements This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future financial results, production expectations and constraints, and plans for future business development activities. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Companys ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with supply chain and production constraints, regulatory oversight, the Companys ability to manage its capital resource issues, competition, the Companys ability to consummate the proposed business combination with SEP Acquisition Corp. and the other factors discussed in detail in the Companys periodic filings with the Securities and Exchange Commission . The Company undertakes no obligation to update any forward-looking statement. Contact: [email protected] Copyright 2024 JCN Newswire . All rights reserved.

View stock analysis, news, and events for Sanuwave Health, Inc.